glp 1 statistics GLP-1 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Use Has More Than

Acetyl GLP-1+GIP supports fat loss and metabolic regulation by mimicking incretin hormones, enhancing insulin sensitivity, and reducing appetite

Combining herbal supplements like moringa with GLP-1 medications requires careful consideration

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

FDA approved the 7.2-mg dose on March 19, and GoodRx has it on shelf less than a month later

Future research should prioritize human trials, bioavailability optimization, and synergistic formulations to harness the full therapeutic potential of plant-derived GLP-1 agonists in metabolic disorders.

Learn about the link between semaglutide, tirzepatide, and gallstone risk, including symptoms to watch for, who faces higher risk, and what to do if complications arise.